Preprint · CC-BY
via OpenAlex
Transcriptomic Signature of Radiation Response in Li-Fraumeni Syndrome
TSpace (University of Toronto) · 2019
Abstract
Li-Fraumeni Syndrome (LFS) is an inherited cancer predisposition disorder associated with a germline mutation in the TP53 tumour suppressor gene. Impaired p53, important in the DNA damage response, has been shown to increase risk of radiation-induced second malignancy (RISM) in LFS patients. We hypothesize that a transcriptomic signature of RISM risk in LFS can be established and used as a predictive tool. LFS patient skin-derived fibroblast cell lines were used to demonstrate transcriptomic differences in patients that developed a RISM relative to those with long-term disease-free survival (LTDFS) post-radiation therapy. Potential RISM signature genes identified were additionally screened for involvement in radiation response and tumorigenic priming. The interconnected Wnt and hedgehog signaling pathways encompassed many of the proposed genes. Development of a RISM signature in LFS has potential to optimize treatment for LFS patients including modification of initial treatment and post-radiation surveillance for those considered high risk of RISM.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-10-15 MST
Cite this
APA
Sauberli-Stewart, K. (2019). Transcriptomic Signature of Radiation Response in Li-Fraumeni Syndrome. <em>TSpace (University of Toronto)</em>. https://openalex.org/W3123171567
Vancouver
Sauberli-Stewart K. Transcriptomic Signature of Radiation Response in Li-Fraumeni Syndrome. TSpace (University of Toronto). 2019.
BibTeX
@unpublished{katherine2019Transc,
title = {Transcriptomic Signature of Radiation Response in Li-Fraumeni Syndrome},
author = {Katherine Sauberli-Stewart},
journal = {TSpace (University of Toronto)},
year = {2019},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Clinical and Translational Radiation Oncology 2017
Open access · CC-BY
Increasing genomic instability during cancer therapy in a patient with Li-Fraumeni syndrome
Blood 2025
Open access · OA
Telomere attrition is common in patients with germline RUNX1 pathogenic variants
The Journals of Gerontology Series A 2017
Open access · CC-BY
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty
The Journal of Frailty & Aging 2026
Open access · CC-BY
Insights on geroscience pre-clinical and clinical trials to promote healthy aging from the Intrinsic Capacity, Frailty and Sarcopenia Research Task Force 2025
The Journal of frailty & aging 2026
Open access · OA
Insights on geroscience pre-clinical and clinical trials to promote healthy aging from the Intrinsic Capacity, Frailty and Sarcopenia Research Task Force 2025.
Pharmacology & therapeutics 2026
Citation only